Kindall G. Jackson


Kindall Jackson represents both investment banks and issuers across a variety of public and private capital markets transactions including initial public offerings and other equity offerings, high-yield and investment-grade debt offerings, follow-on offerings, PIPEs and ATM offerings. Kindall also regularly counsels publicly traded companies on general corporate matters, including SEC reporting and corporate governance.

Download full bio 


  • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion 

  • Aura Biosciences – $86.7 Million Follow-on Offering 

  • Cerevel Therapeutics – $253.8 Million Follow-on Offering and Concurrent $345.0 Million Rule 144A Convertible Notes Offering 

  • Verona Pharma – $150 Million Follow-on Offering 

  • Verve Therapeutics – $258.8 Million Follow-on Offering 

  • View all


  • Columbia Law School
    JD, 2019

  • University of Washington
    BA, Political Science

Admissions & Credentials

New York

District of Columbia


  • New York City Bar Association